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PRIMARY TRACK: Guideline development SECONDARY TRACK: Guideline appraisal BACKGROUND (INTRODUCTION):
The Healthcare National Reference Centre (HNRC) was originally established to support health care funding in the Czech Republic. Later, this institution undertook more tasks focused on development of national sets of clinical guidelines and quality indicators. To establish an effective tool for the Czech health care system, we harnessed the experience of many competent institutions in the sector of guidelines and quality indicators development. Our system is based on the principle of systematic usage of some of the existing components in the Czech health care system, uses its own methodology of guidelines and indicators development, EBM methodology, process algorithmization, and systematic derivation of the quality indicators from clinical criteria and clinical recommendations.
LEARNING OBJECTIVES (TRAINING GOALS):
1. Understand a new methodology with joined "life cycle" of guidelines and indicators development.
2. Identify weaknesses in the health care system and its improvement by using clinical criteria. METHODS: The Czech health care system uses comprehensive national "administrative" databases such as insurance billing data or national health care statistics, but also many extensive "clinic-specific" databases such as national cancer database and other clinical registers for cardiology, hip replacements, etc. We use some of these data for designing and testing quality and performance indicators in coordination with clinical guidelines development. We plan to use some of these "clinic-specific" databases in the near future for the same purposes. RESULTS: It has been two years since we started assessing significant benefits, especially in cancer prevention, and introducing arrangements enhancing care in some specialties while simultaneously developing guidelines and indicators. The poster presents the general framework of our methodology and some of the examples of joined guidelines and indicators, focusing on weaknesses in the health care system and its improvement.
DISCUSSION (CONCLUSION):
In our experience, the joined development of national sets of clinical guidelines and quality indicators and its implementation yield measurable benefits in improvement of the health care system TARGET AUDIENCE(S): 1. Guideline developer 2. Guideline implementer 3. Developer of guideline-based products 4. Quality improvement manager/facilitator 5. Health care policy analyst/policy-maker
